117 related articles for article (PubMed ID: 3926955)
21. Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes.
Saiki I; Sone S; Fogler WE; Kleinerman ES; Lopez-Berestein G; Fidler IJ
Cancer Res; 1985 Dec; 45(12 Pt 1):6188-93. PubMed ID: 3933823
[TBL] [Abstract][Full Text] [Related]
22. Gamma-interferon-induced monocyte major histocompatibility complex class II antigen expression individuals with acquired immune deficiency syndrome.
MartÃnez-Maza O; Mitsuyasu RT; Miles SA; Giorgi JV; Heitjan DF; Sherwin SA; Fahey JL
Cell Immunol; 1989 Oct; 123(2):316-24. PubMed ID: 2507169
[TBL] [Abstract][Full Text] [Related]
23. IFN-gamma-induced production of monocyte cytotoxic factor.
Kildahl-Andersen O; Espevik T; Nissen-Meyer J
Cell Immunol; 1985 Oct; 95(2):392-406. PubMed ID: 3930074
[TBL] [Abstract][Full Text] [Related]
24. A lymphokine distinct from interferon-gamma that activates human monocytes to kill Leishmania donovani in vitro.
Hoover DL; Finbloom DS; Crawford RM; Nacy CA; Gilbreath M; Meltzer MS
J Immunol; 1986 Feb; 136(4):1329-33. PubMed ID: 3080522
[TBL] [Abstract][Full Text] [Related]
25. Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.
Keller R; Keist R; Van der Meide PH; Groscurth P; Aguet M; Leist TP
J Immunol; 1987 Apr; 138(7):2366-71. PubMed ID: 3104463
[TBL] [Abstract][Full Text] [Related]
26. Reversible defect in antigen-induced lymphokine and gamma-interferon generation in cutaneous leishmaniasis.
Murray HW; Rubin BY; Carriero S; Acosta AM
J Immunol; 1984 Oct; 133(4):2250-4. PubMed ID: 6432909
[TBL] [Abstract][Full Text] [Related]
27. The effects of Con A-induced lymphokines from the T-lymphocyte subpopulations on human monocyte leishmanicidal capacity and H2O2 production.
Passwell JH; Shor R; Gazit E; Shoham J
Immunology; 1986 Oct; 59(2):245-50. PubMed ID: 2945777
[TBL] [Abstract][Full Text] [Related]
28. Human monocyte-mediated cytotoxicity against herpes simplex virus-infected cells: activation of cytotoxic monocytes by free and liposome-encapsulated lymphokines.
Koff WC; Showalter SD; Chakrabarty MK; Hampar B; Ceccorulli LM; Kleinerman ES
J Leukoc Biol; 1985 Apr; 37(4):461-72. PubMed ID: 3882870
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.
Sampson-Johannes A; Carlino JA
J Immunol; 1988 Nov; 141(10):3680-6. PubMed ID: 3053901
[TBL] [Abstract][Full Text] [Related]
30. Suppression by interleukin 4 of activation of human blood monocytes to the tumoricidal state.
Nishioka Y; Sone S; Okubo A; Ogura T
Jpn J Cancer Res; 1990 Sep; 81(9):936-41. PubMed ID: 2121695
[TBL] [Abstract][Full Text] [Related]
31. Lymphokine stimulation of human macrophage C2 production is partially due to interferon-gamma.
Sanders KM; Littman BH
J Immunol; 1986 Aug; 137(3):876-9. PubMed ID: 3088114
[TBL] [Abstract][Full Text] [Related]
32. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
Kern DE; Grabstein KH; Okuno K; Schreiber RD; Greenberg PD
J Immunol; 1989 Dec; 143(12):4308-16. PubMed ID: 2687379
[TBL] [Abstract][Full Text] [Related]
33. Recombinant human gamma interferon enhances in vitro activation of lymphocytes isolated from patients with acquired immunodeficiency syndrome.
Heagy W; Strom TB; Kelley VE; Collela J; Crumpacker C; Williams JM; Shapiro HM; Laubenstein L; Finberg R
Infect Immun; 1989 Nov; 57(11):3619-28. PubMed ID: 2572558
[TBL] [Abstract][Full Text] [Related]
34. Expression of interleukin 2 receptors by monocytes from patients with acquired immunodeficiency syndrome and induction of monocyte interleukin 2 receptors by human immunodeficiency virus in vitro.
Allen JB; McCartney-Francis N; Smith PD; Simon G; Gartner S; Wahl LM; Popovic M; Wahl SM
J Clin Invest; 1990 Jan; 85(1):192-9. PubMed ID: 2295695
[TBL] [Abstract][Full Text] [Related]
35. Immunomodulating effects in vitro of interleukin-2 and interferon-gamma on human blood and bone marrow mononuclear cells.
Kedar E; Rezai AR; Giorgi JV; Gale RP; Champlin RE; Mitsuyasu RT; Fahey JL
Nat Immun Cell Growth Regul; 1988; 7(1):13-30. PubMed ID: 2896298
[TBL] [Abstract][Full Text] [Related]
36. [Induction of human monocyte-mediated tumor cell killing by alpha or beta interferon].
Utsugi T; Mutsuura S; Ogawara M; Shirahama T; Ishii K; Tsubura E; Sone S
Gan To Kagaku Ryoho; 1985 May; 12(5):1105-10. PubMed ID: 3994398
[TBL] [Abstract][Full Text] [Related]
37. Role of interleukin 1 in promoting human monocyte-mediated tumor cytotoxicity.
Onozaki K; Matsushima K; Kleinerman ES; Saito T; Oppenheim JJ
J Immunol; 1985 Jul; 135(1):314-20. PubMed ID: 3873493
[TBL] [Abstract][Full Text] [Related]
38. IFN-alpha and IFN-gamma can affect both monocytes and tumor cells to modulate monocyte-mediated cytotoxicity.
Webb DS; Gerrard TL
J Immunol; 1990 May; 144(9):3643-8. PubMed ID: 2158515
[TBL] [Abstract][Full Text] [Related]
39. Tumoricidal activity of interferon-r activated peripheral monocytes in colorectal cancer patients.
Chang KJ; Lee CS; Wang SM; Hsieh KH; Chen KM
J Formos Med Assoc; 1991 Jan; 90(1):15-23. PubMed ID: 1715383
[TBL] [Abstract][Full Text] [Related]
40. The role of monocyte cytotoxic factor (CF) in cytostasis mediated by IFN-gamma-activated monocytes.
Kildahl-Andersen O; Nissen-Meyer J
Immunology; 1985 Oct; 56(2):367-72. PubMed ID: 3932193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
